New Deal
Frank Yu
Founder and CEO at ALLY BRIDGE GROUP
Investor
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (18)
Key Relationships
Announcement Date
Deal Value
Rapid Micro Biosystems
Ally Bridge Group
£97m
9 dealmakers
Cerevel Therapeutics
Ecor1 Capital
£1,002m
66 dealmakers
Chinook Therapeutics
£80m
15 dealmakers
GRAIL
Illumina
£6,190m
107 dealmakers
Miragen Therapeutics
VENROCK
£70m
19 dealmakers
Nautilus Biotechnology
Arya Sciences Acquisition Corp Iii
£654m
44 dealmakers
SYAPSE
£49m
Vida Health
Ngp Capital
£79m
16 dealmakers
Hummingbird Bioscience
Frazier Healthcare Partners
£88m
18 dealmakers
Nikang Therapeutics
Surveyor Capital
£141m
29 dealmakers
Cmr Surgical
Tencent Holdings
£425m
Sonoma Biotherapeutics
Casdin Capital
£190m
Arbor Biothechnologies
Tcg Crossover
£159m
5 dealmakers
Shoreline Biosciences
Eventide Asset Management
£102m
BENEVOLENTAI
Temasek Holdings
£1,282m
71 dealmakers
ALZHEON
£8m
3 dealmakers
Cg Oncology
£101m
12 dealmakers
£133m
8 dealmakers